Related Experiment Video
Updated: Jul 10, 2026
04:47
Measuring Transcellular Interactions through Protein Aggregation in a Heterologous Cell System
Published on: May 22, 2020
Inter-conversion of neuregulin2 full and partial agonists for ErbB4
Kristy J Wilson1, Christopher P Mill, Elizabeth M Cameron
1Purdue University School of Pharmacy, Purdue Cancer Research Center, HANS 114, 201 S. University Street, West Lafayette, IN 47907-2064, USA.
Biochemical and Biophysical Research Communications
|October 20, 2007
Summary
Neuregulin 2 beta (NRG2beta) effectively triggers ErbB4 phosphorylation and coupling for Interleukin-3 (IL3) independence. Specific mutations reveal that Gln43 in NRG2beta is crucial for this NRG2-mediated ErbB4 coupling.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Research
Background:
- Neuregulin 2 (NRG2) exists as splice variants, NRG2alpha and NRG2beta, with distinct signaling capabilities.
- These isoforms interact with the ErbB4 receptor tyrosine kinase, influencing downstream cellular processes.
- Understanding isoform-specific functions is key to deciphering ErbB4-mediated signaling pathways.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying the differential effects of NRG2alpha and NRG2beta on ErbB4.
- To identify the specific residues responsible for NRG2beta's potent stimulation of ErbB4 phosphorylation and coupling.
- To investigate the role of NRG2 in achieving Interleukin-3 (IL3) independence in ErbB4-dependent cells.
Main Methods:
- Site-directed mutagenesis was employed to generate specific NRG2 mutants (e.g., NRG2beta Q43L, NRG2alpha K45F, NRG2alpha L43Q/K45F).
- ErbB4 tyrosine phosphorylation and its coupling to IL3 independence were assessed using biochemical assays.
- Ligand purity, glycosylation, and stability were evaluated to rule out technical artifacts.
Main Results:
- NRG2beta potently stimulates ErbB4 phosphorylation and coupling to IL3 independence.
- NRG2alpha exhibits lower affinity for ErbB4 and fails to efficiently stimulate phosphorylation and coupling.
- Mutational analysis identified Gln43 in NRG2beta as essential and sufficient for mediating ErbB4 coupling to IL3 independence, independent of ligand affinity.
Conclusions:
- Gln43 of NRG2beta is a critical determinant for its ability to induce ErbB4 coupling and promote IL3 independence.
- The differential signaling of NRG2 isoforms is primarily mediated by specific amino acid residues, not just receptor affinity.
- These findings provide insights into NRG2-ErbB4 signaling and its potential role in cancer progression.
Related Concept Videos
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:00Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:30Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.